Aldosterone as a determinant of cardiovascular and renal dysfunction

J R Soc Med. 2001 Aug;94(8):378-83. doi: 10.1177/014107680109400803.
No abstract available

Publication types

  • Review

MeSH terms

  • Aldosterone / physiology*
  • Angiotensin II / metabolism
  • Animals
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Endothelium, Vascular / metabolism
  • Fibrosis
  • Humans
  • Kidney Diseases / drug therapy
  • Kidney Diseases / metabolism*
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Nitric Oxide / metabolism
  • Potassium / metabolism
  • Randomized Controlled Trials as Topic
  • Sodium / metabolism
  • Spironolactone / therapeutic use

Substances

  • Mineralocorticoid Receptor Antagonists
  • Angiotensin II
  • Spironolactone
  • Nitric Oxide
  • Aldosterone
  • Sodium
  • Potassium